Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Embrella Cardiovascular Inc.

Division of Edwards Lifesciences Corp.

Latest From Embrella Cardiovascular Inc.

CardioLogical Solutions: Combining Forces To Deliver A Range Of TAVI Accessories

The recently announced merger of two innovative cardiovascular device companies – VasoStitch Inc. and Emboline Inc. – under the name CardioLogical Solutions promises to create a full range of accessory devices to improve the safety and efficacy of transcatheter aortic valve implantation (TAVI) procedures performed by either an interventional cardiologist or a thoracic surgeon.

Medical Device

Vascular Access Technologies Inc.

Central venous access continues to be linked to an abnormally high risk of serious and life-threatening complications. Unintended damage to major organs results from the “blind” placement of a hollow needle through the patient’s skin and into the target vein. Vascular Access Technologies Inc. hopes to reduce complications with SAFECVAD, a novel steerable catheter that uses the femoral vein as its point of entry. It is observed under fluoroscopy as it follows a simple guided path to the jugular or subclavian vein, where it makes a visible “inside-out” exit at the exact desired location for central line catheter placement.

Medical Device

Top Device Stories Of 2011: Living In A State Of Transition

EBI’s device team reviews of the top news stories in the medical device industry in 2011. Top stories include: 510(k) reform, user-fees, VC money dries up for medtech, hot clinical spaces of the year, where private investment dollars went in 2011, big changes at J&J, and the new physician/hospital alignments and their impact on the medical device industry.

Medical Device Business Strategies

Emboline Inc.

While the focus of aortic embolic protection has previously been limited to stroke prevention, Emboline Inc. believes the concern should be broader because there are other complications that can be caused by emboli moving downstream, resulting in diminished function or failure of other organs, such as the kidneys. The company’s Emboline CAP device provides complete protection of the arterial system from these emboli, thanks to a central filter enabled by an access port that allows for tool access through the filter.

Medical Device
See All

Company Information

  • Industry
  • Medical Devices
    • Implantable Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
  • Therapeutic Areas
  • Cardiovascular
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Edwards Lifesciences Corp.
  • Senior Management
  • Jeffrey F O'Donnell, CEO
    Carol Burns, VP, Product & Bus. Dev.
    Jeffrey P Carpenter, MD, CSO
  • Contact Info
  • Embrella Cardiovascular Inc.
    Phone: (610) 783-1100
    880 E. Swedesford Rd.
    Ste. 220
    Wayne, PA 19087